Category > Discover Digital Health Startups in Drug Discovery

Discover Digital Health Startups in Drug Discovery

As of September 2024, the Drug Discovery category has a total of 282 Digital Health firms. The total venture volume has expanded at a CAGR of 7.5% over the past 5 years. The ventures have an average venture maturity score of 54.9.

From a funding perspective, these Digital Health companies have successfully raised $15.11B in venture capital investments, channeled through 635 distinct funding rounds. In the past 12 months, total venture capital funding closed at $3.94B across 81 deals.

Last Updated: September 07, 2024

Ventures

Venture	Primary Category	Country	Therapeutic Focus	Valuation	Stage	Current Funding
Benchling	Drug Discovery	United States	xyrsttzsas	$ 123.46 B	Series F	$ 100.00 M
DNAnexus	Drug Discovery	United States	xyrsttzsas	$ 123.46 B	Series G	$ 200.00 M
Formation Bio	Drug Discovery	United States	xyrsttzsas	$ 123.46 B	Series D	$ 372.00 M
CytoReason (סיטוריזון)	Drug Discovery	Israel	xyrsttzsas	$ 123.46 B	Series B	$ 80.00 M
Scorpion Therapeutics	Drug Discovery	United States	xyrsttzsas	$ 123.46 B	Series C	$ 150.00 M
PhoreMost	Drug Discovery	United Kingdom	xyrsttzsas	$ 123.46 B	Series B1	$ 12.00 M
BenchSci	Drug Discovery	Canada	xyrsttzsas	$ 123.46 B	Series D	$ 69.77 M
Atomwise	Drug Discovery	United States	xyrsttzsas	$ 123.46 B	Series B	$ 123.00 M
BioAge Labs	Drug Discovery	United States	xyrsttzsas	$ 123.46 B	Series D	$ 170.00 M
Valo Health	Drug Discovery	United States	xyrsttzsas	$ 123.46 B	Series B1	$ 110.00 M

Showing 1 to 10 of 282 entries